By 
Waud Capital Partners announced its partnership with healthcare distribution executive Bill Mixon to pursue a medical device and supply chain services platform backed by over $100 million in equity capital. The collaboration represents founder Reeve Waud’s continued commitment to healthcare consolidation opportunities and demonstrates the firm’s established approach of pairing sector expertise with proven executive talent.
The partnership announcement reinforces Waud Capital Partners’ position as a leading healthcare services investor under Reeve Waud’s guidance. Since founding the firm in 1993, he has built a reputation for identifying fragmented healthcare markets and supporting experienced executives in building market-leading companies.
Three Decades of Private Equity Excellence Under Reeve Waud Leadership
Reeve Waud’s investment career spans over 30 years, during which he has overseen more than 500 company acquisitions. His approach emphasizes fundamental value creation through operational improvements and targeted consolidation rather than financial engineering alone.
The firm’s growth trajectory reflects Reeve Waud’s methodical approach to building a sustainable private equity platform. Starting as a one-person operation in Lake Forest, Illinois, Waud Capital Partners has grown to manage approximately $4.6 billion in assets under management with nearly 70 dedicated professionals (https://www.waudcapital.com/en/media/waud-capital-partners-celebrates-30-years-of-partnership/).
This expansion has enabled Waud Capital Partners to pursue increasingly sophisticated investment opportunities while maintaining the hands-on approach that has characterized Reeve Waud’s most successful deals. The firm’s healthcare portfolio includes notable successes like Acadia Healthcare, which he founded in 2005 and continues to chair as an independent director.
Reeve Waud’s healthcare investing expertise began with his recognition of consolidation opportunities within behavioral health services. His founding of Acadia Healthcare created a platform that grew to operate over 260 facilities across 40 states and Puerto Rico, demonstrating the scalability of well-executed healthcare consolidation approaches.
The firm’s successful exit from GI Alliance, valued at approximately $2.2 billion in 2022, further validated Reeve Waud’s approach to healthcare services investing. That transaction involved building the largest independent gastroenterology practice management company in the nation through systematic consolidation of fragmented regional practices.
Partnership Approach Drives Next Healthcare Investment
The partnership with Bill Mixon exemplifies the investment philosophy that has guided Reeve Waud throughout his career at Waud Capital Partners. Rather than simply providing capital, the firm actively seeks experienced executives who can drive operational improvements and market consolidation within attractive healthcare sectors.
“We are thrilled to partner with Bill,” said Mike Lehman, Principal at Waud Capital. “He is an exceptional executive who has created value and driven multiple successful outcomes throughout his career in a sector we find highly attractive.”
Mixon’s background aligns with the type of executive partnership that has characterized Reeve Waud’s most successful healthcare investments. His experience growing Advanced Diabetes Supply to $1 billion in revenue while serving nearly 500,000 patients demonstrates the scaling potential that attracts Waud Capital Partners’ attention.
The medical device and supply chain services opportunity represents a natural extension of Reeve Waud’s healthcare investment thesis. The targeted sectors—home distribution, specialty distribution, outsourced provider equipment services, and chronic care management—exhibit the fragmentation and consolidation potential that have driven previous successes.
Reeve Waud’s continued involvement as Chairman of Acadia Healthcare provides ongoing insight into healthcare market dynamics and operational challenges. This sector expertise informs new investment decisions and helps identify executives capable of executing successful consolidation approaches.
The firm’s established relationships within healthcare, built through investments like Acadia Healthcare and GI Alliance, provide competitive advantages in sourcing attractive opportunities and supporting portfolio company growth plans.
“I’m excited to partner with Waud Capital to identify and help build what we hope will be an industry-leading business that supports and improves the overall healthcare supply chain,” Mixon stated, acknowledging the value of Waud Capital Partners’ executive partnership approach and dedicated ecosystem resources.
This latest partnership demonstrates Reeve Waud’s ongoing commitment to healthcare investing and his ability to identify both attractive market opportunities and the experienced executives capable of capturing them. The combination has consistently generated substantial returns for Waud Capital Partners and its investors across multiple healthcare market cycles.
Related: Acadia Healthcare taps former Humana executive for CEO
Comments